Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Arimoclomol for treating glucocerebrosidase associated disorders

Arimoclomol for treating glucocerebrosidase associated disorders

US Patent 11253505 · Granted Feb 22, 2022

Estimated economic value: $3,123,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of Hsp70 as a regulator of enzymatic activity2024
Use of HSP70 as a regulator of enzymatic activity2022
Arimoclomol formulation2022
Arimoclomol formulation2022
Use of Hsp70 as a regulator of enzymatic activity2021
Selective inhibition of V1b for treating fatty liver2021
Heat shock proteins and cholesterol homeostasis2021
Arimoclomol formulation2020
Arimoclomol formulation2020
Use of Hsp70 as a regulator of enzymatic activity2020
Methods for increasing intracellular activity of Hsp702020
Methods for increasing intracellular activity of Hsp702020